Point-of-care fluorescence imaging developer MolecuLight will present six clinical posters, a presentation, and a hands-on workshop at the American Professional Wound Care Association's Wound Week, being held September 20 to 24 in Philadelphia.
Wound Week is a multidisciplinary meeting of wound care professionals that presents clinical findings and best practices presented by expert faculty.
The following are the clinical posters to be presented throughout the week:
- 12-week RCT Evaluating Impact of Routine Fluorescence Imaging of Bacteria on DFU Healing Rates
- Pseudomonas Scrub Down: Advances in Wound Imaging Objectively Confirm the Efficacy of Acetic Acid Against this Pathogen
- Bacterial load imaging of chronic wound bacteria supports patient adherence, empowerment, and may prevent negative outcomes
- Strategies to improve equity in wound bacterial-infection assessments on skin of color
- Multimodal imaging device for real-time bacterial load and thermal imaging: a study of synergy in clinical wound assessment workflow
- Antimicrobial prescribing trends in 1,447 outpatient wound assessments: baseline rates and impact of bacterial fluorescence imaging
The clinical presentation will highlight MolecuLight's point-of-care device. Alisha Oropallo from the Northwell Comprehensive Wound Healing Center will describe objective targeting and validation of patient-reported, wound-associated pain through MolecuLight's device.
The company's i:X and DX imaging devices will be showcased at a hands-on skills workshop in MolecuLight's booth.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
